Post by account_disabled on Jan 14, 2024 7:07:47 GMT
Drug development is an arduous process, from identification to formulation, development, and clinical trial before a therapeutic drug gets approval, it undergoes multiple clinical trials to ensure its safety and efficacy. The traditional drug discovery model fails to provide quick results, and hundreds of drug discoveries never enter the market. The conventional approach requires animal or human models to understand the reaction of the drug—it takes time, and in some cases, results are not clear. Furthermore, genetic variations in disease-causing bacteria and humans may impact the reaction of drugs, making it difficult for the researchers to design drug considering these factors. Discovery of a potential drug is a complex and long process.
The daunting process and numerous clinical trials raise the gap between B2C Cell Phone Number List drug discovery and commercialization. Organ-on-a-chip technology emerges as an innovative approach to speed up the drug discovery process. It is a tech-driven cell culture model that resembles human physiology and provides data about drug pharmacokinetics accurately bridging the gap between drug development and approval for commercialization. The organ on-chip has become the future of drug designing, allowing researchers to invest time in finding innovative solutions to combat diseases. Organ on a Chip: The Future of Drug Discovery Organ-on-a-chip technology, also known as tissue chips, contains natural or engineered tissues derived from human organs such as the liver, heart, lungs, and more.
The extracted tissue is grown in the miniaturized fluid channel, which is molded into silicon, glass, and polymer. Organ on a chip effectively mimics human physiology—helping pharmaceutical players to understand the drugs and their reactions in real time. The aim of designing an organ on a chip is to create a cellular micro-environment for the study of drug efficacy. It significantly helps to reduce the time of research and bridges the gap between commercialization and clinical trial of drugs. How Does Organ On A Chip Technology Work? Organ on a chip combines microfluidics and cell culture to imitate the psychology of the human body organs and disease states such as gaseous exchange in the lungs, peristalsis in the intestines, and flow of blood through the vasculature.
The daunting process and numerous clinical trials raise the gap between B2C Cell Phone Number List drug discovery and commercialization. Organ-on-a-chip technology emerges as an innovative approach to speed up the drug discovery process. It is a tech-driven cell culture model that resembles human physiology and provides data about drug pharmacokinetics accurately bridging the gap between drug development and approval for commercialization. The organ on-chip has become the future of drug designing, allowing researchers to invest time in finding innovative solutions to combat diseases. Organ on a Chip: The Future of Drug Discovery Organ-on-a-chip technology, also known as tissue chips, contains natural or engineered tissues derived from human organs such as the liver, heart, lungs, and more.
The extracted tissue is grown in the miniaturized fluid channel, which is molded into silicon, glass, and polymer. Organ on a chip effectively mimics human physiology—helping pharmaceutical players to understand the drugs and their reactions in real time. The aim of designing an organ on a chip is to create a cellular micro-environment for the study of drug efficacy. It significantly helps to reduce the time of research and bridges the gap between commercialization and clinical trial of drugs. How Does Organ On A Chip Technology Work? Organ on a chip combines microfluidics and cell culture to imitate the psychology of the human body organs and disease states such as gaseous exchange in the lungs, peristalsis in the intestines, and flow of blood through the vasculature.